In recognition of November as Lung Cancer Awareness Month, the Montefiore Einstein Comprehensive Cancer Center unveiled the Jack D. Weiler Hospital's newly ...

The American Lung Association released its 2024 "State of Lung Cancer" report, highlighting a 26% increase in survival and a 15% decrease in incidence, though care disparities across state lines and ...

Certain chronic conditions that affect the lungs, such as asthma and chronic obstructive pulmonary disease (COPD), can have ...

American Lung Association’s ‘State of Lung Cancer’ report reveals stark differences in survival, screening and treatment across states ...

Zorifertinib is the first drug in the world to launch a registration clinical trial specifically for advanced NSCLC with CNS metastases and achieve remarkable results. It is also the only* EGFR ...

Source: Getty Images “Metformin may improve lung cancer-specific clinical outcomes in obese and overweight lung cancer patients and enhance immunotherapy efficacy in this growing population as well,” ...

The firms will initially develop a tool to identify NSCLC patients with EGFR mutations who can benefit from targeted therapy.

Lung12, patients will be screened with the GRAIL assay prior to surgery to inform eligibility for post-surgery randomization to an adjuvant treatment regimen ( NCT06564844 ). Assay performance was ...

Initiative aims to strengthen diagnostic capabilities in the public sector, providing Kenyan patients with access to ...

Collaboration to harness Lunit SCOPE Genotype Predictor for rapid and convenient prediction of non-small cell lung cancer ...

Novotech, the global full-service clinical CRO, has published a new report, Small Cell Lung Cancer: Global Clinical Trial ...

Lung cancer is the most prevalent and deadly cancer in the world. With the promotion of CT scanning and the public's rising ...